Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | Pyruvate dehydrogenase lipoamide kinase | 0.1607 | 1 | 0.5 |
Trypanosoma cruzi | developmentally regulated phosphoprotein, putative | 0.1607 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1607 | 1 | 0.5 |
Trypanosoma brucei | developmentally regulated phosphoprotein | 0.1607 | 1 | 0.5 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.1607 | 1 | 0.5 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.1607 | 1 | 0.5 |
Leishmania major | developmentally regulated phosphoprotein-like protein | 0.1607 | 1 | 0.5 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.1607 | 1 | 1 |
Toxoplasma gondii | ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein | 0.0651 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ED50 (functional) | = 9.09 mg kg-1 | Effective dose against pentylenetetrazol intoxicity in mice administered orally | ChEMBL. | 2861285 |
ED50 (functional) | = 9.09 mg kg-1 | Effective dose against pentylenetetrazol intoxicity in mice administered orally | ChEMBL. | 2861285 |
ED50 (functional) | = 11.14 mg kg-1 | Effective dose against pentylenetetrazol intoxicity in mice administered through subcutaneous route | ChEMBL. | 2861285 |
ED50 (functional) | = 11.14 mg kg-1 | Effective dose against pentylenetetrazol intoxicity in mice administered through subcutaneous route | ChEMBL. | 2861285 |
Inhibition (functional) | = 67 % | Percent inhibition against tetrabenazine induced ptosis in mice administered subcutaneously at 50 mg/kg | ChEMBL. | 2861285 |
Inhibition (functional) | = 67 % | Percent inhibition against tetrabenazine induced ptosis in mice administered subcutaneously at 50 mg/kg | ChEMBL. | 2861285 |
K2 (binding) | = 0.038 uM | Binding constant was determined by displacing potential to [3H]-diazepam binding in cerebral cortex homogenates of rat | ChEMBL. | 2861285 |
K2 (binding) | = 0.038 uM | Binding constant was determined by displacing potential to [3H]-diazepam binding in cerebral cortex homogenates of rat | ChEMBL. | 2861285 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.